Updated:26 May 2017 03:31:00 PM(IST)
|Bse Corporate Announcements||Back|
|Outcome of board meeting of Cipla|
|Cipla announced that the Board of Directors of the Company at its meeting held on 20 July 2015, approved a potential investment by FIL Capital Investments (Mauritius) II Limited, or any of its affiliate in a wholly owned subsidiary of Cipla (proposed to be incorporated) to whom Cipla will be divesting its consumer healthcare business on a going-concern basis.
The approval is subject to execution of binding agreements, and the transaction will be subject to relevant regulatory approvals. None of the persons belonging to Promoter / Promoter Group(s) of the Company has any interest in the transaction.